Biotech

All Articles

Lilly- supported weight-loss biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has submitte...

Aelis' cannabis make use of drug flunks stage 2b, steering Indivior to rethink $100M option

.Aelis Farma's chances of safeguarding a quick, favorable selection on a $100 million choice remitta...

ProKidney stops stage 3 test certainly not needed to have for tissue treatment permission

.ProKidney has actually stopped some of a set of period 3 tests for its tissue treatment for kidney ...

Vaxcyte surges on 'stunning' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what experts called "spectacular" stage 1/2 records for its 31-valent pneumococcal...

Recursion's brain condition trial shows scant evidence of efficiency

.Recursion has discovered with a very early examination of its own tech-enabled method to drug revel...

Acepodia, Pfizer click on with each other for chemistry-based tissue treatment

.Call it an instance of excellent chemical make up: Acepodia, a biotech based upon Nobel Champion sc...

Praxis epilepsy medicine lessens seizures in stage 2 litigation

.Practice Preciseness Medicines has scored an additional midphase succeed in epilepsy this year, alo...

Three execs surrender as Dyne messages combined data for DMD applicant

.After getting away a scientific hold numerous years back, Dyne Therapeutics has actually shown new ...

Arrowhead fires off phase 3 records in unusual metabolic ailment ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually revealed its own hand ahead of a potential face-off along wi...

Pfizer, Valneva reveal lyme ailment try helpful for 2nd enhancer

.Pfizer and Valneva might have concerning pair of even more years to stand by prior to they produce ...